600 patients66,869 observations120 daysLIVE

Patient P-01796

Synthetic patientNBL-101 · Day 116 · 75+ · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
6%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S09
  2. Day 53 SC-12 recommendedSupportive Compound SC-12
  3. Day 54 Patient acceptedStarted SC-12 in the companion
  4. Day 60 GI symptom burden −14% vs expectedSupportive Compound SC-12
  5. Day 66 Tolerance state changedUnstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Inflammatory activity-11
  • GI instability-9
  • Nutritional resilience+2

What helped?

  • Supportive Compound SC-12Day 53
    Result: symptom burden −14%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
10.4/100
improving · -4.2 vs previous 14 d
Toxicity
Blood
14.1/100
worsening · +4.2 vs previous 14 d
Sleep quality
Wearable
57.7/100
improving · +5.9 vs previous 14 d
Energy level
Daily log
7.3/10
improving · +0.4 vs previous 14 d
Stress level
Daily log
3.4/10
improving · -0.2 vs previous 14 d
Steps
Wearable
9,362
stable · +47 vs previous 14 d
Adherence
Companion
94.8 %
stable · +0.8 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 100 from the failing basin, 14 from restoration.

Good elements to keep
  • Supportive Compound SC-12
    intervention · steering +24.2
  • Butyrate producers intact
    hidden · steering +7.5
Main detractors to watch
  • Alcohol
    perturbation · steering -9.4
  • Bacteroides fragilis elevated
    hidden · steering -7.4
  • Antibiotic course
    perturbation · steering -4.7
  • Poor-sleep week
    perturbation · steering -3
  • Alcohol
    detractor · GI +5.2 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Alcohol
    +5.2detractor · 95%
  • Histamine load
    -2.6no signal · 52%
  • Spicy / capsaicin
    -1.7no signal · 35%
  • Insoluble fibre
    -1.2no signal · 22%
  • Simple carbohydrates
    -0.9no signal · 15%
  • Dietary fat load
    +0.8no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 35
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 36 ms, trending down
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.6 · butyrate capacity 64/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
36 ms
Sleep
7.3 h
Steps
8,941
Resting HR
71 bpm
Daily log: GI score 10, nutritional resilience 69, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0176644%S05AD-05no change90
P-0180429%S19AD-05improved61
P-0154124%S09AD-05no change43
P-0149550%S07BR-03improved85
P-0132944%S08BR-03improved79
P-0167740%S05BR-03no change86
P-0165457%S08CR-01improved85
P-0143025%S05CR-01improved54
P-0147937%S15DT-01improved84
P-0185534%S04DT-01improved73
P-0176730%S14DT-01no change63
P-0172429%S10DT-01improved63